Metraipolis › archive › dc_d41289a5473e

Optimizing ciltacabtagene autoleucel outcomes: real-world experience and best practices from a single academic center — Europe PMC PMID:42518817

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42518817
DOI
10.3389/fonc.2026.1841031
License (as archived)
solo-consultazione
Archived
2026-10-18T11:01:49.301Z
SHA-256 of the archived text
8e3f294060b5d2e911a555022790380471b4edd22d92ea49cb781f3c7481ae55
Stable URL of this page
https://metraipolis.com/documento/dc_d41289a5473e

How to cite

Optimizing ciltacabtagene autoleucel outcomes: real-world experience and best practices from a single academic center — Europe PMC PMID:42518817 — Europe PMC (en), https://europepmc.org/article/MED/42518817 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d41289a5473e (Metraipolis archive dc_d41289a5473e, sha256 8e3f294060b5d2e911a555022790380471b4edd22d92ea49cb781f3c7481ae55)
BibTeX
@misc{dcd41289a5473e,
  title = {Optimizing ciltacabtagene autoleucel outcomes: real-world experience and best practices from a single academic center — Europe PMC PMID:42518817},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42518817},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d41289a5473e; sha256 8e3f294060b5d2e911a555022790380471b4edd22d92ea49cb781f3c7481ae55},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42518817. Agents can read the archived copy with the MCP tool read_document.